BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
-11.11%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$7.07B
AUM Growth
-$1.54B
(-18%)
Cap. Flow
-$234M
Cap. Flow
% of AUM
-3.31%
Top 10 Holdings %
Top 10 Hldgs %
34.72%
Holding
187
New
10
Increased
57
Reduced
82
Closed
15
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$58.1M |
| 2 |
Pfizer
PFE
|
$41.4M |
| 3 |
Harmony Biosciences
HRMY
|
$28.1M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$25.4M |
| 5 |
Celldex Therapeutics
CLDX
|
$24.9M |
Top Sells
| 1 |
Elevance Health
ELV
|
$98M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$85.7M |
| 3 |
AbbVie
ABBV
|
$47.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
$46.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$42.9M |
Sector Composition
| 1 | Healthcare | 98.26% |
| 2 | Industrials | 0.38% |
| 3 | Energy | 0.03% |
| 4 | Communication Services | 0.01% |
| 5 | Technology | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Kezar Life Sciences
KZR
$28M
| $25.1M | 0.35% |
303,500
-163,315
| -35% | -$13.5M |
|
|
77
Celldex Therapeutics
CLDX
$1.51B
| $24.9M | 0.35% |
+925,000
| New | +$24.9M |
|
78
Penumbra
PEN
$10.9B
| $24M | 0.34% |
192,588
-1,066
| -0.6% | -$133K |
|
79
Generation Bio
GBIO
$38.9M
| $23.8M | 0.34% |
362,728
-5,490
| -1% | -$360K |
|
80
Teleflex
TFX
$5.7B
| $23.6M | 0.33% |
95,984
-1,730
| -2% | -$425K |
|
81
BioNTech
BNTX
$24.9B
| $22.5M | 0.32% |
151,200
+39,434
| +35% | +$5.88M |
|
82
Beam Therapeutics
BEAM
$1.88B
| $22.2M | 0.31% |
572,621
-10,200
| -2% | -$395K |
|
83
MacroGenics
MGNX
$123M
| $21.6M | 0.31% |
7,325,514
| – | – |
|
84
HUTCHMED
HCM
$2.55B
| $21.4M | 0.3% |
1,756,307
+5,617
| +0.3% | +$68.3K |
|
85
CVS Health
CVS
$93.5B
| $21.2M | 0.3% |
229,153
-3,202
| -1% | -$297K |
|
86
Castle Biosciences
CSTL
$670M
| $20.7M | 0.29% |
941,059
+333,445
| +55% | +$7.32M |
|
87
Procept Biorobotics
PRCT
$2.13B
| $19.5M | 0.28% |
595,380
+309,305
| +108% | +$10.1M |
|
88
Hologic
HOLX
$14.8B
| $18.8M | 0.27% |
270,825
-4,958
| -2% | -$344K |
|
89
Transmedics
TMDX
$3.55B
| $18.2M | 0.26% |
579,887
-1,142
| -0.2% | -$35.9K |
|
90
Mersana Therapeutics
MRSN
$35.5M
| $18M | 0.25% |
155,808
-2,352
| -1% | -$272K |
|
91
ResMed
RMD
$40.1B
| $17.8M | 0.25% |
84,865
-1,484
| -2% | -$311K |
|
92
Phreesia
PHR
$1.86B
| $17M | 0.24% |
680,153
+99,655
| +17% | +$2.49M |
|
93
Illumina
ILMN
$15.5B
| $16M | 0.23% |
89,299
+8,209
| +10% | +$1.47M |
|
94
ESSA Pharma
EPIX
$11M
| $15.8M | 0.22% |
5,009,714
-25,100
| -0.5% | -$79.1K |
|
95
Avantor
AVTR
$8.99B
| $15.6M | 0.22% |
503,007
-9,209
| -2% | -$286K |
|
96
Privia Health
PRVA
$2.84B
| $15.1M | 0.21% |
519,876
-5,124
| -1% | -$149K |
|
97
Wave Life Sciences
WVE
$1.3B
| $14.6M | 0.21% |
4,494,458
-68,400
| -1% | -$222K |
|
98
Teladoc Health
TDOC
$1.35B
| $13.8M | 0.2% |
416,112
+52,896
| +15% | +$1.76M |
|
99
Amgen
AMGN
$151B
| $12.4M | 0.18% |
50,959
-2,841
| -5% | -$691K |
|
100
Scholar Rock
SRRK
$3.12B
| $11.8M | 0.17% |
2,152,025
-32,400
| -1% | -$178K |
|